Antibiotic Stewardship. Matthew Dryden MD Hampshire Hospitals, Southampton University
|
|
- Kerry Fitzgerald
- 5 years ago
- Views:
Transcription
1 Antibiotic Stewardship Matthew Dryden MD Hampshire Hospitals, Southampton University
2 Overview The Problem What antibiotic have achieved Antibiotic stewardship Rapid diagnostics Antibiotic strategy New antibiotics
3 We can not remember a time before antibiotics Antibiotics have saved more lives than any type of drug Antibiotics are different from all other drugs because their action is targeted against the invaders physiology rather than the host Antibiotic stewardship is complementary to infection control
4 Sir Luke Fildes 1891 The Doctor Tate Gallery, London
5 What antibiotics have achieved Major reductions in mortality Mortality, Pre- Antibiotic Mortality Postantibiotic Change (%) Community pneumonia 1 ~35 ~10 71 Hospital pneumonia 2 ~60 ~30 50 Endocarditis ~25 75 Meningitis / brain infection 4 ~80 ~23 71 Skin / soft tissue infection 5 ~11 ~ IDSA Position Paper 08 Clin Infect Dis 47 (S3): S249-65; 2IDSA/ACCP/ATS/SCCM Position Paper 10 Clin Infect Dis In Press; 3Kerr AJ. Subacute Bacterial Endocarditis. Springfield IL: Charles C. Thomas, 1955 & Lancet :383-4; 4 Lancet :733-4 & Waring et al. 48 Am J Med 5:402-18; 5 Spellberg et al. 09 Clin Infect Dis 49: & Madsen 73 Infection 1:76081
6 Antibiotics a finite resource Diagnostic limitations mean that antibiotics are given to patients who have no infection or a viral infection Antibiotics are life saving in sepsis Empirical treatment is often very broad De-escalation rarely occurs Duration often too long Dryden MS, Cooke J, Davey P JAC. 2009; 64,
7 Antibiotic discovery Selective pressure and resistance Antibiotic treatment Public health, Infection prevention, and control
8 Whatever happens in India, happens in large numbers
9 Boost Antibiotic discovery Reduce Selective pressure and resistance REDUCE VOLUME of Antibiotic use IMPROVE Public health, Infection prevention, and control
10
11 Questionable use of antibiotics Where Antibiotics are used Types of use Questionable use Human use (50%) 20% hospital 80% community 20-50% Unnecessary Agricultural use (50%) 20% Therapeutic 80% Prophylactic growth promotion 40-80% Highly questionable Harrison PF, Lederberg J, eds. Antimicrobial resistance: issues and options. Washington, DC: National Academy Press, 1998
12 Megraj room, 1st floor, Commonwealth Building, Hammersmith Campus, W12 0NN
13
14
15 MRSA as % S. aureus bacteraemias 2010 vs Up >25% Down >25%
16 Rise and fall of MRSA bacteraemias in the UK The black line shows the number of cases in England (only) reported under the mandatory scheme initiated in 2001, and the grey bars show percent MRSA amongst all S. aureus bacteraemias reported under the Health Protection Agency s voluntary surveillance, covering >90% of hospitals in England, Wales and Northern Ireland 1, first recognition of EMRSA-15 and -16 2, initiation of mandatory surveillance of MRSA bacteraemias 3, beginning of decline of EMRSA-16 4, issue of Department of Health targets for MRSA reduction Livermore DM. Int J Antimicrob Agents 2012;39:283 94
17 Intercontinental Exchanges of CA-MRSA Clones ST8, ST59, ST80, ST30 DeLeo FR, et al. Lancet 2010; 375:
18 E. coli from bloodstream infections: Turning nasty Cephalosporins: 2001/10 Quinolones: 2001/10
19 Mortality in ESBL vs. non-esbl Enterobacteriaceae bacteraemia Schwaber & Carmeli JAC :
20 Falling dominoes: Carbapenem-resistant K. pneumoniae, EARS-net Initially spread of VIM plasmids among K. pneumoniae in Greece From 2008 spread of K. pneumoniae ST258 with KPC enzyme
21 Pan-resistant Gram negative Klebsiella pneumoniae from ICU patients Susceptibility profile: Carboxy-pen. Ureido-pen. BLICs Cefepime Ceftazidime Cefotaxime Imipenem Meropenem R R R R R R R R Amikacin Gentamicin Tobramycin Netilmicin Tetracycline SXT Chloramph. R R R R R R R Miriagou et al. JAC 2005; 55:810 Production of: VIM-1 MBL SHV-5 ESBL
22 A precious resource The aim is not to preserve antibiotics The aim to continue to have drugs to treat infection To better target antibiotics for patients who will benefit Volume of AB use= Selection pressure We must reduce the volume of antibiotic use And improve public health & infection control
23 Strategies to reduce antibiotic overuse 1. Diagnose infection more accurately 2. New antibiotic classes and antimicrobial therapy 3. Antibiotic guidelines and stewardship 4. Infection management and early discharge
24 Diagnostics Can we target antibiotic use better with rapid diagnostics? Need to give antibiotics to the patients who can benefit, NOT to patients for which there is NO benefit.
25 Accelerating microbiology Potential to revolutionise stewardship Now. 24 h to pure culture 48 h to susceptibility data Meanwhile the patient is on empirical R x May be inappropriate --- or unnecessarily broad
26 Accelerating microbiology Potential to revolutionise stewardship & therapy Future. PCR on specimen Recognise key pathogens and a few resistances some systems available Next generation sequencing Comprehensive pathogen and resistance detection.under development Potential to deliver results in 6h benefitting patient and stewardship. but much work still to do
27
28 Little et al Lancet 2013
29 Diagnostics to improve stewardship Procalcitonin trial Royal Hampshire Hospital 99 Medical Admissions Unit (MAU) patients; also 42 ICU patients with 87 procalcitonin tests Procalcitonin results within 90 minutes of request Antibiotics withheld in 52/99 MAU cases and on 42/87 ICU occasions based on low procalcitonin 6 MAU patient died: deaths NOT infection related 5 ICU patients died with infection, all receiving antibiotics Saeed K, Dryden MS, Bourne S, Paget C, Proud A. Journal of Hospital Infection 2011;78(4), ;doi: /j.jhin
30
31 UK Five-Year Antimicrobial Resistance Strategy 2013 to strategic aims: Improve the knowledge and understanding of AMR Conserve and steward the effectiveness of existing treatments Stimulate the development of new antibiotics, diagnostics and novel therapies
32 7 key areas for future action 1. improving infection prevention and control practices in human and animal health 2. optimising prescribing practice through implementation of antimicrobial stewardship programmes 3. improving professional education, training and public engagement 4. developing new drugs and diagnostic tests
33 7 key areas for future action 5. better access to and use of surveillance data 6. better identification and prioritisation of AMR 7. strengthened international collaboration
34 Getting it right
35 Right drug: in sepsis, early antibiotics are critical Mortality increases with each hour s delay Fraction of total patients Survivors if antibiotic initiation takes stated period Fraction on adequate antibiotics Time from hypotension onset (h) Adequate antimicrobial therapy should start within 1 hour Kumar et al. Crit Care Med 2006;34:
36 Frequency (% patients) Mortality (% patients) Right drug Resistance makes empirical therapy harder Inappropriate Dead No. resistances
37 Good stewardship General principles Start smart, then focus Start antibiotics immediately in severe infection Right drug, right dose and right duration Document, review and audit Have stewardship team Ensures compliance, audit and update
38 Start Smart with empirical antibiotics and within 1h in life-threatening infections Don t start without clinical evidence of infection Use local guidelines to choose appropriate antibiotic - Should reflect likely pathogens & patient risk factors for resistant strains - Consider relevant allergies and interactions Obtain specimens for culture before dosing Document: indication, duration/review time, route & dose - Record on drug chart and in medical notes
39 Right drug- risk of collateral damage C. difficile risk varies with therapy
40 Right drug: once microbiology results available typically 48h after specimen / R x initiation Clinical & microbiology review STOP iv/oral switch Move to narrow spectrum agent Continue & re-review after 24h OPAT
41 Right drug: Why switch to oral? Rationales are clinical and economic More convenient for patient May be possible to discharge patient i.v. sites are portal for super-infection Cost Caveat.. Don t use oral drugs based on microbiology if they lack the clinical indication, e.g. fosfomycin for ascending UTI due to ESBL E. coli
42 Concentration Right dose Pharmacodynamics vary with drug class C max = Peak C max / MIC T > MIC b-lactams Aminoglycosides AUC / MIC Fluoroquinolones Macrolides Glycopeptides Tetracyclines Oxazolidinones MIC Time
43 Right dose Ensure efficacy whilst minimising resistance Excessive dose may increase toxicity Depends on drug class Under-dosage may promote selection of resistance Lack of good evaluations Was seen in 200 vs 600 mg linezolid trials Combinations especially with aminoglycosides often increase toxicity without improving outcomes
44 Right duration Lack of good studies, BUT Excessively long durations associated with More collateral damage to normal flora No improvement in outcomes Excessively short durations associated with Failures Selection of resistance e.g. in tuberculosis
45 8 Days R x or 15 days in ventilator pneumonia? Kaplan-Meier estimates of patient survival in VAP No increase of mortality or recurrence Longer R X still advised with P. aeruginosa CAVEAT Trial comparing 7 days doripenem (1g tds) vs 10 days imipenem (1 tds) in VAP stopped owing to worse outcomes in doripenem arm.
46 The Stewardship Team reports to Director of Infection Control & Prevention & to Drugs & therapeutics committee Microbiologist / Infectious Disease physician Antimicrobial / Infectious Disease pharmacist A lead clinician A surgeon Senior member of pharmacy team Senior nurse, ensuring links to infection control
47 Roles of the stewardship team Review and audit, ensuring Regular review of local guidelines Regular review of stewardship practice Regular review of organisation s antibiotic consumption Overall use, and at ward level Especially of broad spectrum agents Identification and discussion of any non-compliance
48 Antibiotic Stewardship in Europe European: 170 hospitals in32 countries Hospital has: Drugs & Therapeutics Committee North n=19 (%) West n=55 (%) South n=40 (%) Southeast n=13 (%) Central east n=43 (%) Total n=170 (%) 19 (100) 53 (98) 27 (68) 9 (69) 38 (88) 146 (86) Written formulary 16 (84) 51 (94) 23 (59) 5 (42) 36 (84) 131 (77) Formulary lists restricted antibiotics 7 (39) 36 (71) 21 (78) 7 (78) 32 (82) 103 (61) Written AB policy 15 (79) 39 (72) 18 (46) 3 (25) 22 (54) 97 (57) Antibiotic committee 14 (74) 30 (57) 17 (45) 4 (31) 24 (56) 89 (52) Prescription improvement as a strategic goal No AB committee or AB policy 8 (44) 32 (59) 17 (45) 5 (46) 25 (61) 87 (51) 2 (5) 7 (19) 13 (35) 6 (16) 9 (24) 37 (22) DTC = Drugs and Therapeutics Committee; AB = Antibiotic; SE = Southeast; CE = Central-East Bruce J, et al. J Antimicrob Chemother. 2009;64:
49 Challenges and uncertainties It is easier to regulate than to be right How restrictive should guidelines be? Class restriction Cycling, Diversity among appropriate agents Can we use biomarkers to better guide therapy? How can microbiology be accelerated to shorten the period of empirical treatment?
50 Three models of empirical Rx control Restrictive policy, cycling & diversity Restrictive B & C only for microdirected therapy A A A A A A A A A A A A B B B C C C Cycling A B C A B C A B C Diverse 3 month periods
51 Restrictive policy or guideline One favoured empirical therapy per setting Simple, easy to audit / enforce Has come apply de facto in the UK for severe infection Piperacillin-tazobactam hugely used; carbapenems reserved; cephalosporins & quinolones restricted owing to fear of C. difficile Concentrates selection pressure on few agents Led to sequential loss of therapies in gonorrhoea Sulphonamides, penicillin, quinolones abandoned in turn Cephalosporin MICs now creeping upwards
52 Carbapenem Cephalosporin Pip/tazo No Pip/tazo No Cephalosporin No Carbapenem Antibiotic diversity vs. cycling & restriction Prospective cohort study 44 months, one ICU Months 1-10 Patient Specific Months Priority / Cycling Months Single agents restricted Months Mixing Physician choice, based on risk factors Sequential patients allocated to different R x
53 Positive isolates/100 admissions Different strategies to control resistance One unit, lot of caveats, but mixing & choice seem best 1 Acinetobacter solid, carbapenem R 2 Enterobacteria ESBL 3 P. aeruginosa any R 4 S. aureus methicillin R 5 E. faecalis Physician choice Cycling Restriction Mixing
54 Restriction vs. cycling vs. diversity Caveat one study, one unit.. Prioritization (cycling) & restriction increased homogeneity - Associated with colonisation by Enterobacteriaceae and gram-negative non-fermenters - Outbreaks of carbapenem-r Acinetobacter during carbapenem prioritization - ESBL-producing Enterobacteriaceae during cephalosporin prioritization Patterns favouring diverse use were less damaging Implies that guidelines should list reasonable R x options but allow choice among them
55 Assessing the future
56
57 Dwindling supply of new antibiotics FDA approvals by 5-year period
58 Antibiotics A brief interlude in human history Age of ignorance Age of discovery golden age Age of the antibiotic revolution Age of neglect Age of reality Silver. Clin Microbiol Rev 2011;24:71 109
59 Comparison of novel Antimicrobials Drug Vancomycin / teicoplanin Quinupristin/ dalfopristin Linezolid Daptomycin Ceftaroline Tigecycline Dalbavancin Advantages Familiarity, long history of use. Poor for CAP Alternative to vancomycin. Hardly used now Positive pharmacoeconomic outcome data are available. Oral dosing removal of catheters, early discharge, evidence of superiority to vancomycin in cssti and pneumonia Potential for less resistance, bactericidal. cssti, bacteraemia Broad spectrum. B-lactam; cssti, CAP Broad spectrum, fixed dosages, cssti, IAI Long acting (weekly dosing), bactericidal, cssti
60 Surgihoney: in vitro activity
61 77 year old man Peripheral vascular disease Large ischaemic ulcers Non healing Heavily colonised with coliforms and Pseudomonas aeruginosa.
62
63 Who will win? Louis Pasteur: Messieurs, c est les microbes qui auront le dernier mot
Appropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationModels for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist
Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist philip.howard2@nhs.net Twitter: @AntibioticLeeds United Kingdom of England, Scotland, Wales & Northern Ireland
More informationThe UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England
The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England Chief Medical Officer - Annual Report 2013 Antimicrobial resistance poses catastrophic
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationAntimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services
Antimicrobial Stewardship/Statewide Antibiogram Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda CMS and JCAHO
More informationNosocomial Infections: What Are the Unmet Needs
Nosocomial Infections: What Are the Unmet Needs Jean Chastre, MD Service de Réanimation Médicale Hôpital Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, Paris 6, France www.reamedpitie.com
More informationAntimicrobial Stewardship Program: Local Experience
Antimicrobial Stewardship Program: Local Experience Dr. WU Tak Chiu Associate Consultant Division of Infectious Diseases Department of Medicine Queen Elizabeth Hospital 18th January 2011 QUEEN ELIZABETH
More informationNew Drugs for Bad Bugs- Statewide Antibiogram
New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationJump Starting Antimicrobial Stewardship
Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing
More informationAntimicrobial stewardship: Quick, don t just do something! Stand there!
Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger
More informationCollecting and Interpreting Stewardship Data: Breakout Session
Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline
More informationAntimicrobial stewardship
Antimicrobial stewardship Magali Dodemont, Pharm. with the support of Wallonie-Bruxelles International WHY IMPLEMENT ANTIMICROBIAL STEWARDSHIP IN HOSPITALS? Optimization of antimicrobial use To limit the
More informationAntimicrobial stewardship in managing septic patients
Antimicrobial stewardship in managing septic patients November 11, 2017 Samuel L. Aitken, PharmD, BCPS (AQ-ID) Clinical Pharmacy Specialist, Infectious Diseases slaitken@mdanderson.org Conflict of interest
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationWorkplan on Antibiotic Usage Management
IMPACT Forum: Antibiotic Guideline in Perspective Workplan on Antibiotic Usage Management Dr. Raymond Yung Consultant Microbiologist PYNEH 20 April 2002 May 2002 Dr. Raymond Yung 1 Objective 1. Heighten
More informationANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT
ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT CLINICAL GUIDELINES ID TAG Title: Prepared by Specialty / Division: Directorate: Antimicrobial Stewardship
More informationThe Rise of Antibiotic Resistance: Is It Too Late?
The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationMAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges
Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationIntroduction to antimicrobial resistance
Introduction to antimicrobial resistance Philip Howard Consultant Antimicrobial Pharmacist HCAI and AMR Project Lead 4 th March 2015 What is antimicrobial resistance? Antibacterials either kill or stop
More informationMono- versus Bitherapy for Management of HAP/VAP in the ICU
Mono- versus Bitherapy for Management of HAP/VAP in the ICU Jean Chastre, www.reamedpitie.com Conflicts of interest: Consulting or Lecture fees: Nektar-Bayer, Pfizer, Brahms, Sanofi- Aventis, Janssen-Cilag,
More information10 Golden rules of Antibiotic Stewardship in ICU. Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017
10 Golden rules of Antibiotic Stewardship in ICU Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017 10 golden rules of Antibiotic Stewardship in the ICU ID, Pharma & Micro advice
More informationSustaining an Antimicrobial Stewardship
Sustaining an Antimicrobial Stewardship Much needless expense, untoward effect, harm and disappointment can be prevented by better judgment in the use of antimicrobials Whitney A. Jones, PharmD Antimicrobial
More informationAntimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD
Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an
More informationStewardship tools. Dilip Nathwani Ninewells Hospital and Medical School Dundee, UK
Stewardship tools Dilip Nathwani Ninewells Hospital and Medical School Dundee, UK What is Antimicrobial Stewardship (AMS)? Antimicrobial stewardship has been defined as the optimal selection, dosage, and
More informationAdvances in Antimicrobial Stewardship (AMS) at University Hospital Southampton
Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton Dr Julian Sutton Consultant in Infectious Diseases & Medical Microbiology Federation of Infection Societies 1 st December,
More informationAntimicrobial Stewardship 101
Antimicrobial Stewardship 101 Betty P. Lee, Pharm.D. Pediatric Infectious Disease/Antimicrobial Stewardship Pharmacist Lucile Packard Children s Hospital Stanford Disclosure I have no actual or potential
More informationEnglish Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Berit Muller-Pebody HCAI & AMR Department, Centre for Infectious Disease Surveillance and Control Chief Medical Officer
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationAntimicrobial Resistance Update for Community Health Services
Antimicrobial Resistance Update for Community Health Services Elizabeth Beech Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England October 2015 elizabeth.beech@nhs.net Superbugs
More informationFighting MDR Pathogens in the ICU
Fighting MDR Pathogens in the ICU Dr. Murat Akova Hacettepe University School of Medicine, Department of Infectious Diseases, Ankara, Turkey 1 50.000 deaths each year in US and Europe due to antimicrobial
More informationApril 25, 2018 Edited by: Gregory K. Perry, PharmD, BCPS-AQID
VOLUME FOUR; ISSUE 4 April 25, 2018 Edited by: Gregory K. Perry, PharmD, BCPS-AQID InPHARMation Pharmacy and Therapeutics Committee Update April 25 th, 2018 Meeting The Pharmacy and Therapeutics Committee
More informationLEARNING OBJECTIVES ANTIMICROBIAL USES AND ABUSES INFECTIOUS DISEASE SCARES
LEARNING OBJECTIVES ANTIMICROBIAL USES AND ABUSES Goodbye to the Antibiotic Era? Glenn D. Bedsole, MD, FACP Infectious Disease Consultant 1. Be able to list 6 examples of resistant bacteria that present
More informationDr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College
Dr. Shaiful Azam Sazzad MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College INTRODUCTION ICU acquired infection account for substantial morbidity, mortality and expense. Infection and
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationUpdate on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital
Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia Po-Ren Hsueh National Taiwan University Hospital Ventilator-associated Pneumonia Microbiological Report Sputum from a
More informationSuccessful stewardship in hospital settings
Successful stewardship in hospital settings Pr Charles-Edouard Luyt Service de Réanimation Institut de Cardiologie Groupe Hospitalier Pitié-Salpêtrière Université Pierre et Marie Curie, Paris 6 www.reamedpitie.com
More informationResponsible use of antibiotics
Responsible use of antibiotics Uga Dumpis MD, PhD Department of Infectious Diseases and Infection Control Pauls Stradiņs Clinical University Hospital Challenges in the hospitals Antibiotics are still effective
More informationSepsis is the most common cause of death in
ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic
More informationThese recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.
Antibiotic regimens for suspected hospital-acquired infection (HAI) outside the Paediatric Intensive Care Unit at Red Cross War Memorial Children s Hospital (RCWMCH) Lead author: Brian Eley Contributing
More informationWhy Antimicrobial Stewardship?
Antimicrobial Stewardship: Why and How CAPT Arjun Srinivasan, MD Associate Director for Healthcare Associated Infection Prevention Programs Division of Healthcare Quality Promotion Why Antimicrobial Stewardship?
More informationMisericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014
H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report July December 213 Second and Third Quarters
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationAntimicrobial Stewardship Esperienza Torinese
Pisa 15 Novembre 2016 Antimicrobial Stewardship Esperienza Torinese Francesco G. De Rosa Dipartimento di Scienze Mediche Università di Torino Antimicrobial Stewardship First introduced by Dale Gerding
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationOriginal Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):
Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S
More informationAntimicrobial Stewardship:
Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationPromoting Appropriate Antimicrobial Prescribing in Secondary Care
Promoting Appropriate Antimicrobial Prescribing in Secondary Care Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2015 Introduction Background ESPAUR
More informationAntibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011
Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationGlobal Status of Antimicrobial Resistance with a Focus on Nepal
Global Status of Antimicrobial Resistance with a Focus on Nepal John Ferguson, John Hunter Hospital, University of Newcastle, NSW, Australia Infectious Diseases Physician and Medical Microbiologist SIMON
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationAntibiotic Stewardship in the Hospital Setting
Antibiotic Stewardship in the Hospital Setting G. Evans, MD FRCPC Medical Director, Infection Prevention & Control Kingston General Hospital & Hotel Dieu Hospital EOPIC September 26, 2012 Stewardship stew-ard-ship
More informationAntimicrobial Stewardship. Where are we now and where do we need to go?
Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR 2017 @SPC2016Cork Antimicrobial Stewardship. Where are we now and where do we need to go? Frank O Riordan Antimicrobial pharmacist,
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More informationAntibacterial Resistance: Research Efforts. Henry F. Chambers, MD Professor of Medicine University of California San Francisco
Antibacterial Resistance: Research Efforts Henry F. Chambers, MD Professor of Medicine University of California San Francisco Resistance Resistance Dose-Response Curve Antibiotic Exposure Anti-Resistance
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationOutline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010
Multi-Drug Resistant Organisms Is Combination Therapy the Way to Go? Sutthiporn Pattharachayakul, PharmD Prince of Songkhla University, Thailand Outline Prevalence of anti-microbial resistance in Acinetobacter
More informationAntibiotic treatment in the ICU 1. ICU Fellowship Training Radboudumc
Antibiotic treatment in the ICU 1 ICU Fellowship Training Radboudumc Main issues Delayed identification of microorganisms Impact of critical illness on Pk/Pd High prevalence of antibiotic resistant strains
More informationGrey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report
H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report to 214 Table of Contents I. Introduction..
More informationPIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
More informationPOTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS
POTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS Dirk VOGELAERS Department of General Internal Medicine, Infectious Diseases and Psychosomatic Medicine
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationDr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust
Dr Eleri Davies Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Antimicrobial stewardship What is it? Why is it important? Treatment and management of catheter-associated
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationDisclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials
Disclosures Principles of Antimicrobial Therapy None Lori A. Cox MSN, ACNP-BC, ACNPC, FCCM Penn State Hershey Medical Center Neuroscience Critical Care Unit Obtaining an Accurate Diagnosis Determine site
More informationKonsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program
Konsequenzen für Bevölkerung und Gesundheitssysteme Stephan Harbarth Infection Control Program University of Geneva Hospitals Outline Introduction What data sources are available? AMR-associated outcomes
More informationANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized
More informationThe trinity of infection management: United Kingdom coalition statement
* The trinity of infection management: United Kingdom coalition statement This coalition statement, on behalf of our organizations (the UK Sepsis Trust, Royal College of Nursing, Infection Prevention Society,
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationPractical application of antibiotic use data. Uga Dumpis MD PhD Pauls Stradins Clinical University Hospital University of Latvia
Practical application of antibiotic use data Uga Dumpis MD PhD Pauls Stradins Clinical University Hospital University of Latvia No conflict of interest Questions for the ACASEM Survey Question 1. Antimicrobial
More informationConsumption of antibiotics in hospitals. Antimicrobial stewardship.
Consumption of antibiotics in hospitals. Antimicrobial stewardship. Inge C. Gyssens MD PhD Radboud university medical center, Nijmegen, The Netherlands Hasselt University, Belgium 1. Antibiotic use in
More informationLe infezioni di cute e tessuti molli
Le infezioni di cute e tessuti molli SCELTE e STRATEGIE TERAPEUTICHE Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi Treatment of complicated skin and skin structure infections
More informationScottish Medicines Consortium
Scottish Medicines Consortium tigecycline 50mg vial of powder for intravenous infusion (Tygacil ) (277/06) Wyeth 9 June 2006 The Scottish Medicines Consortium (SMC) has completed its assessment of the
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP Adrie Bekker - Kenya 2018 Department of Pediatric and Child Health, Division of Neonatology University of Stellenbosch, Tygerberg Hospital DEFINITION OF ANTIMICROBIAL STEWARDSHIP
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationSt. Joseph s General Hospital Vegreville. and. Mary Immaculate Care Centre. Antimicrobial Stewardship Report
St. Joseph s General Hospital Vegreville and Mary Immaculate Care Centre Antimicrobial Stewardship Report January to June 217 Introduction Antibiotics are among the most commonly prescribed medications
More informationRole of IV Therapy in Bone and Joint Infection
Role of IV Therapy in Bone and Joint Infection Andrew Seaton ID Consultant, Queen Elizabeth University Hospital Lead Doctor Antimicrobial Management Team, NHS GGC @raseaton66 OPAT The IVnOAT Perspective
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationMDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC
MDRO s, Stewardship and Beyond Linda R. Greene RN, MPS, CIC linda_greene@urmc.rochester.edu Evolving Threat of Antimicrobial Resistance Why are MDROs important? Limited treatment options Associated with:
More informationReducing the Burden of Severe Sepsis and Infections in Indian ICUs
Reducing the Burden of Severe Sepsis and Infections in Indian ICUs J.V. Divatia Professor & Head Department of Anaesthesia, Critical Care & Pain Tata Memorial Hospital Mumbai India Infections in the ICU
More informationBest Practices: Goals of Antimicrobial Stewardship
Best Practices: Goals of Antimicrobial Stewardship Gail Scully, M.D, M.P.H. and Elizabeth Radigan, PharmD, BCPS UMass Memorial Medical Center Division of Infectious Disease Department of Medicine September
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationAntimicrobial resistance and the need for stewardship. Dr Nick Brown RCP Acute Medicine conference, 16 April 2018
Antimicrobial resistance and the need for stewardship Dr Nick Brown RCP Acute Medicine conference, 16 April 2018 Fleming s laboratory, St Mary s Hospital, London (Photo N M Brown ) It is not difficult
More information